Ka Wai Kam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ka Wai Kam has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Clement Cy Tham
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
21 shared publications - Jason C. Yam
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Kowloon, China
20 shared publications Chi Pui Pang
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China
19 shared publications- Li Jia Chen
Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong, China
18 shared publications Alvin L Young
Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
15 shared publications- Alvin Lerrmann Young
Department of Ophthalmology and Visual Sciences; Prince of Wales Hospital, The Chinese University of Hong Kong; Hong Kong China
15 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (11) , 101406
Anisometropia, Strabismus, and Amblyopia in Children with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and Their Comorbidity
- 9 September 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (11) , 101406
Open AccessAnisometropia, Strabismus, and Amblyopia in Children with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and Their Comorbidity
- 4 September 2026
- Published by BMJ in British Journal of Ophthalmology
Education and myopia prevalence in children from kindergarten to primary school: an exploratory mediation analysis from the Hong Kong children eye study
Purpose: To assess the role of education on myopia prevalence and refractive status in children enrolled in kindergarten and the early grades of primary school. Methods: In this population-based, cross-sectional study, children from primary schools and kindergartens were recruited prior to the onset of the COVID-19 pandemic in January 2020. Cycloplegic autorefraction and axial length (AL) were measured in all children. Data on parental myopia, family income and children’s lifestyle factors were collected via a standard questionnaire. Mediation analyses were used to explore the influence of education on myopia prevalence, spherical equivalent (SE) and AL. Results: In 2525 kindergarten children (413 in grade 2 /(K2) and 2112 in grade 3 (K3)) and 9018 primary school children (4250 in grade 1 (P1) and 4768 in grade 2 (P2)), myopia prevalence increased with academic grade: 7.6% of K2, 8.7% K3, 17.3% P1 and 29.1% P2. AL was longer in K3 than in K2 children (p<0.001) although SE did not differ (p=0.18). Exploratory analyses suggested statistical mediation by education duration in the association between age and myopia-related outcomes. Among kindergarten children, parental myopia was the sole factor associated with myopia prevalence, SE and AL. For primary school children, schooling duration in P1, age, sex, family income and parental myopia were associated with myopia prevalence, SE and AL. Conclusion: The prevalence of myopia significantly increased from kindergarten to primary school with education duration being a possible mediator from primary school onward. Notably, significant changes in AL were observed among kindergarten children.
- 4 September 2026
- Published by BMJ in British Journal of Ophthalmology
Education and myopia prevalence in children from kindergarten to primary school: an exploratory mediation analysis from the Hong Kong children eye study
Purpose: To assess the role of education on myopia prevalence and refractive status in children enrolled in kindergarten and the early grades of primary school. Methods: In this population-based, cross-sectional study, children from primary schools and kindergartens were recruited prior to the onset of the COVID-19 pandemic in January 2020. Cycloplegic autorefraction and axial length (AL) were measured in all children. Data on parental myopia, family income and children’s lifestyle factors were collected via a standard questionnaire. Mediation analyses were used to explore the influence of education on myopia prevalence, spherical equivalent (SE) and AL. Results: In 2525 kindergarten children (413 in grade 2 /(K2) and 2112 in grade 3 (K3)) and 9018 primary school children (4250 in grade 1 (P1) and 4768 in grade 2 (P2)), myopia prevalence increased with academic grade: 7.6% of K2, 8.7% K3, 17.3% P1 and 29.1% P2. AL was longer in K3 than in K2 children (p<0.001) although SE did not differ (p=0.18). Exploratory analyses suggested statistical mediation by education duration in the association between age and myopia-related outcomes. Among kindergarten children, parental myopia was the sole factor associated with myopia prevalence, SE and AL. For primary school children, schooling duration in P1, age, sex, family income and parental myopia were associated with myopia prevalence, SE and AL. Conclusion: The prevalence of myopia significantly increased from kindergarten to primary school with education duration being a possible mediator from primary school onward. Notably, significant changes in AL were observed among kindergarten children.
- Open Access
- 7 August 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Epidemiology of ocular surface squamous neoplasia and squamous papillomas in Hong Kong Chinese: A 10-year review
Background/Aims: We aim to report the risk factors, clinicopathological characteristics, treatment modalities, and outcomes of ocular surface squamous neoplasia (OSSN) and squamous papilloma (SQP) in a Chinese population. Methods: A retrospective cohort study was performed on subjects with histologically proven OSSN and SQP between April 2012 and August 2022 at two hospitals in Hong Kong. Results: Fifty eyes of 48 subjects were analysed, of which 24 were OSSN. The overall ten-year annual incidence rate was 0.34 per 100,000 persons. Men were more commonly affected. Moderate-to-severe dysplastic lesions were more frequently associated with pterygia or pinguecula ( p = 0.034), diffuse growth ( p = 0.0027), and involvement of the cornea and limbus (p = 0.0037) than benign lesions. Malignant lesions more frequently involved the fornix ( p = 0.0086) and involved the inferior quadrant, although the latter did not reach statistical significance. There was no shift in surgical treatment patterns between the periods 2012-2016 and 2017-2022. Recurrence-free survival probabilities were 90% at 6 months and 87.0% at 1, 2 and 3 years, with a median follow-up duration of 24 months (IQR 2–48 months). No tumour-related mortality was recorded. Conclusion: The incidence of OSSN and SQP has remained stable over the last decade in our locality, where the prevalence of the Human Immunodeficiency Virus infection has been low. Male sex and a history of pterygia and/or pinguecula were associated with OSSN in our population. The majority achieved complete resolution following excision with or without adjuvant therapy.
- 7 August 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Open AccessEpidemiology of ocular surface squamous neoplasia and squamous papillomas in Hong Kong Chinese: A 10-year review
Background/Aims: We aim to report the risk factors, clinicopathological characteristics, treatment modalities, and outcomes of ocular surface squamous neoplasia (OSSN) and squamous papilloma (SQP) in a Chinese population. Methods: A retrospective cohort study was performed on subjects with histologically proven OSSN and SQP between April 2012 and August 2022 at two hospitals in Hong Kong. Results: Fifty eyes of 48 subjects were analysed, of which 24 were OSSN. The overall ten-year annual incidence rate was 0.34 per 100,000 persons. Men were more commonly affected. Moderate-to-severe dysplastic lesions were more frequently associated with pterygia or pinguecula ( p = 0.034), diffuse growth ( p = 0.0027), and involvement of the cornea and limbus (p = 0.0037) than benign lesions. Malignant lesions more frequently involved the fornix ( p = 0.0086) and involved the inferior quadrant, although the latter did not reach statistical significance. There was no shift in surgical treatment patterns between the periods 2012-2016 and 2017-2022. Recurrence-free survival probabilities were 90% at 6 months and 87.0% at 1, 2 and 3 years, with a median follow-up duration of 24 months (IQR 2–48 months). No tumour-related mortality was recorded. Conclusion: The incidence of OSSN and SQP has remained stable over the last decade in our locality, where the prevalence of the Human Immunodeficiency Virus infection has been low. Male sex and a history of pterygia and/or pinguecula were associated with OSSN in our population. The majority achieved complete resolution following excision with or without adjuvant therapy.
- 1 June 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (6) , 616-622
Long-term astigmatism reduction with toric intraocular lenses: systematic review
Topic: This study aimed to assess the long-term effectiveness of toric intraocular lenses (IOLs) in reducing refractive astigmatism (RA) at and beyond 1 year, along with long-term rotational stability and reoperation rates. Clinical Relevance: Toric IOLs are widely used to correct corneal astigmatism during cataract surgery. However, most reports are limited to early postoperative outcomes. Methods: We conducted a systematic review of long-term outcomes after toric IOL implantation. We searched Ovid Embase and PubMed using the terms “(toric IOL)” AND “(toric intraocular lens)” AND “(long term)” AND “(outcome)” up to April 11, 2025. Studies reporting outcomes of at least 1 year after implantation in otherwise healthy eyes were included. Eyes with ocular comorbidities other than cataracts were excluded. The primary outcomes were residual RA, IOL rotation, and reoperation rates. The study protocol was registered at PROSPERO (CRD420251154641). Results: 19 studies comprising 15 cohorts, 3 case series, and 1 case report totalling 1180 participants and 1564 eyes were analyzed. The mean follow-up period was 29.9 ± 23.7 (range 12 to 96) months. The mean residual cylinder was −0.65 ± 0.39 D at 1 year ( P < .0001) and −0.80 ± 0.54 D ( P = .01) at 2 years. The mean IOL rotation was 2.27 ± 1.40 and 2.82 ± 1.73 degrees at 1 and 2 years, respectively. 12 IOLs (0.77%) required repositioning. Conclusions: Toric IOL implantation maintains effective astigmatism reduction for up to 2 years. Longer-term data remained scarce. The majority of toric IOLs exhibited excellent rotational stability, and the reoperation rate was low.
- 1 June 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (6) , 616-622
Long-term astigmatism reduction with toric intraocular lenses: systematic review
Topic: This study aimed to assess the long-term effectiveness of toric intraocular lenses (IOLs) in reducing refractive astigmatism (RA) at and beyond 1 year, along with long-term rotational stability and reoperation rates. Clinical Relevance: Toric IOLs are widely used to correct corneal astigmatism during cataract surgery. However, most reports are limited to early postoperative outcomes. Methods: We conducted a systematic review of long-term outcomes after toric IOL implantation. We searched Ovid Embase and PubMed using the terms “(toric IOL)” AND “(toric intraocular lens)” AND “(long term)” AND “(outcome)” up to April 11, 2025. Studies reporting outcomes of at least 1 year after implantation in otherwise healthy eyes were included. Eyes with ocular comorbidities other than cataracts were excluded. The primary outcomes were residual RA, IOL rotation, and reoperation rates. The study protocol was registered at PROSPERO (CRD420251154641). Results: 19 studies comprising 15 cohorts, 3 case series, and 1 case report totalling 1180 participants and 1564 eyes were analyzed. The mean follow-up period was 29.9 ± 23.7 (range 12 to 96) months. The mean residual cylinder was −0.65 ± 0.39 D at 1 year ( P < .0001) and −0.80 ± 0.54 D ( P = .01) at 2 years. The mean IOL rotation was 2.27 ± 1.40 and 2.82 ± 1.73 degrees at 1 and 2 years, respectively. 12 IOLs (0.77%) required repositioning. Conclusions: Toric IOL implantation maintains effective astigmatism reduction for up to 2 years. Longer-term data remained scarce. The majority of toric IOLs exhibited excellent rotational stability, and the reoperation rate was low.
- 16 April 2026
- Published by BMJ in British Journal of Ophthalmology
Socioeconomic status, cardiovascular health and joint associations with incident cataract: a prospective study from UK Biobank
Aims To investigate the interaction and combined effects of cardiovascular health (CVH) and socioeconomic status (SES) on incident cataract risk. Methods This prospective cohort study included 236 248 UK Biobank participants free of cataract at baseline and with complete data on SES and CVH. Incident cataract was ascertained through hospital inpatient and self-reported records. SES was derived from household income, employment and education using latent class analysis, while CVH was assessed via the Life’s Essential 8 (LE8) score. Cataract risk was evaluated using multivariable Cox regression, with interaction and joint effects analyses performed to assess the interplay between SES and CVH. Results This analysis involved 236 248 participants with an average age of 55.5 years (range: 38–73); 51.6% were female and 95.6% were of white ethnicity. Over a median follow-up period of 11.7 years, 26 791 participants (11.3%) developed cataract. Compared with the high SES group, participants with low SES had a significantly higher risk of cataract (HR, 1.30; 95% CI 1.25 to 1.35). Significant additive and multiplicative interactions between SES and CVH on cataract risk were observed. Better CVH substantially mitigated the adverse association of low SES with cataract. Notably, individuals with low SES and poor CVH showed the highest cataract risk (HR, 1.74; 95% CI 1.57 to 1.93) in contrast to those with high SES and optimal CVH. Conclusions Implementing interventions aimed at enhancing both SES and CVH may prove beneficial in preventing or delaying cataract onset. Adhering to the LE8 guidelines to maintain optimal CVH has the potential to alleviate a significant portion of the excess cataract risk associated with socioeconomic disadvantage.
- 16 April 2026
- Published by BMJ in British Journal of Ophthalmology
Socioeconomic status, cardiovascular health and joint associations with incident cataract: a prospective study from UK Biobank
Aims To investigate the interaction and combined effects of cardiovascular health (CVH) and socioeconomic status (SES) on incident cataract risk. Methods This prospective cohort study included 236 248 UK Biobank participants free of cataract at baseline and with complete data on SES and CVH. Incident cataract was ascertained through hospital inpatient and self-reported records. SES was derived from household income, employment and education using latent class analysis, while CVH was assessed via the Life’s Essential 8 (LE8) score. Cataract risk was evaluated using multivariable Cox regression, with interaction and joint effects analyses performed to assess the interplay between SES and CVH. Results This analysis involved 236 248 participants with an average age of 55.5 years (range: 38–73); 51.6% were female and 95.6% were of white ethnicity. Over a median follow-up period of 11.7 years, 26 791 participants (11.3%) developed cataract. Compared with the high SES group, participants with low SES had a significantly higher risk of cataract (HR, 1.30; 95% CI 1.25 to 1.35). Significant additive and multiplicative interactions between SES and CVH on cataract risk were observed. Better CVH substantially mitigated the adverse association of low SES with cataract. Notably, individuals with low SES and poor CVH showed the highest cataract risk (HR, 1.74; 95% CI 1.57 to 1.93) in contrast to those with high SES and optimal CVH. Conclusions Implementing interventions aimed at enhancing both SES and CVH may prove beneficial in preventing or delaying cataract onset. Adhering to the LE8 guidelines to maintain optimal CVH has the potential to alleviate a significant portion of the excess cataract risk associated with socioeconomic disadvantage.
- Open Access
- 12 January 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04015
Associations between the Mediterranean lifestyle and incident age-related eye diseases: a longitudinal analysis from the UK Biobank
Worldwide improvements in socioeconomic status and longer life expectancies have led to a rise in the number of individuals living with blinding ophthalmic conditions and an increase in their average age. Among these, cataract, glaucoma, and age-related macular degeneration (AMD) stand as the principal causes of blindness and visual impairment globally, especially among individuals aged […]
- 12 January 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04015
Open AccessAssociations between the Mediterranean lifestyle and incident age-related eye diseases: a longitudinal analysis from the UK Biobank
Worldwide improvements in socioeconomic status and longer life expectancies have led to a rise in the number of individuals living with blinding ophthalmic conditions and an increase in their average age. Among these, cataract, glaucoma, and age-related macular degeneration (AMD) stand as the principal causes of blindness and visual impairment globally, especially among individuals aged […]
- 20 November 2025
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2025 (11) , CD013550
Topical immunosuppressants for blepharitis in adults
Rationale Blepharitis is a common ocular condition characterized by inflammation of the eyelid margins, which can cause irritating symptoms and ocular surface damage. Conventional treatment of blepharitis consists of eyelid hygiene and artificial tears. To suppress inflammation, topical corticosteroids, with or without antibiotics, are frequently prescribed. However, long‐term use is limited by side effects such as increased intraocular pressure, glaucoma and/or cataract formation. Newer steroid‐sparing topical immunosuppressants have emerged as alternative treatments. Objectives To assess the benefits and harms of topical immunosuppressants for blepharitis in adults. Search methods We searched CENTRAL, MEDLINE, Embase, and three trial registries from inception to 6 April 2025. We searched the reference lists of included studies for any additional studies not identified by the electronic searches. There were no date or language restrictions on the selection of eligible studies. Eligibility criteria We included randomized controlled trials (RCTs) comparing topical immunosuppressants (corticosteroids, cyclosporine, or tacrolimus) of different doses or carrier, with placebo, no treatment, conventional treatment (lid hygiene, artificial tears) or other topical immunosuppressants in adults with blepharitis. We excluded paired‐eye studies and highly specific blepharitis subtypes. Outcomes Our outcomes were: (1) change from baseline in composite (or total) symptom score; (2) change from baseline in tear film breakup time; (3) change from baseline in corneal staining scores; (4) proportion of individuals experiencing symptomatic improvement; (5) reduction in number of or eradication of colonies of positive cultures of bacteria; (6) quality of life measures; (7) economic costs of different topical immunosuppressants; and (8) adverse effects. Risk of bias We used Cochrane's risk of bias (RoB) 2 tool for all outcomes reported in the summary of findings tables. Synthesis methods Two review authors independently selected trials, extracted data, and assessed risk of bias. We used fixed‐effect meta‐analysis to combine data and forest plots to assess heterogeneity, effect size, and direction. We used GRADE to assess the certainty of evidence for each outcome. When meta‐analysis was not possible, we used narrative synthesis. Included studies We included 12 RCTs with 2752 participants (2802 eyes) in total. Six of the trials were conducted in the USA. Topical corticosteroid was the most frequently studied immunosuppressant, followed by cyclosporine and tacrolimus. The point of assessment and duration of treatment ranged from two to 12 weeks. No study measured the proportion of individuals experiencing symptomatic improvement. Synthesis of results We report outcomes of interest for three key comparisons below at four to 12 weeks. No study assessed reduction or eradication of colonies of positive cultures of bacteria, quality of life or economic costs. Topical corticosteroids (with or without antibiotics) versus placebo The evidence is very uncertain about the effects of topical corticosteroids on composite symptom scores (corticosteroids with antibiotics: standard mean difference [SMD] 0.87, 95% confidence interval [CI] 0.31 to 1.44; 2 studies, 57 participants; corticosteroids alone: SMD ‐0.05, 95% CI ‐0.31 to 0.20; 2 studies, 232 participants; very low‐certainty evidence). No study reported tear breakup time. The evidence is very uncertain about the effects of topical corticosteroids on corneal staining scores (corticosteroids with antibiotics: MD 0.70, 95% CI ‐1.05 to 2.45; 1 study, 27 participants; corticosteroids alone: MD 0.50, 95% CI ‐1.22 to 2.22; 1 study, 27 participants); both, very low‐certainty evidence. The adverse event of irritation of the ocular surface was reported narratively and was similar between the two groups. The adverse event of ocular hypertension was reported narratively and not detected in either group in one study where it was reported. Topical corticosteroids (with or without antibiotics) versus antibiotics The evidence for topical corticosteroids was inconclusive. One study found that topical corticosteroid with antibiotic treatment may reduce symptom scores more than antibiotics alone (MD ‐11.34, 95% CI ‐13.13 to ‐9.55; 1 study, 148 participants), whereas the other found that it may have little to no effect (MD 0.40, 95% CI ‐0.11 to 0.91; 1 study, 201 participants); both, low‐certainty evidence. Topical corticosteroids plus antibiotics probably result in greater reduction in corneal staining scores compared with antibiotics alone (MD ‐1.26, 95% CI ‐1.56 to ‐0.96; 1 study, 148 participants; moderate‐certainty evidence). However, this effect was not observed for tear breakup time when antibiotics alone are likely to perform better (MD ‐1.10, 95% CI ‐1.39 to ‐0.81; 1 study, 148 participants; moderate‐certainty evidence). The adverse event of irritation of the ocular surface was reported narratively, and was similar between the two groups. The adverse event of ocular hypertension was reported narratively, and was higher in the corticosteroid (with or without antibiotics) group. Topical cyclosporine versus placebo Topical cyclosporine may have little to no effect on the composite symptom score compared with placebo, but the evidence is very uncertain (SMD 0.15, 95% CI ‐0.27 to 0.57; 2 studies, 90 participants; very low‐certainty evidence). The evidence is very uncertain about the effect of topical cyclosporine on tear breakup time compared with placebo (invasive time: MD 4.70, 95% CI ‐0.24 to 9.64; 1 study, 26 participants, although for non‐invasive time, it may provide a potential benefit: MD 1.59, 95% CI 1.48 to 1.70; 1 study, 64 participants; both very low‐certainty evidence). Topical cyclosporine...
- 20 November 2025
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2025 (11) , CD013550
Topical immunosuppressants for blepharitis in adults
Rationale Blepharitis is a common ocular condition characterized by inflammation of the eyelid margins, which can cause irritating symptoms and ocular surface damage. Conventional treatment of blepharitis consists of eyelid hygiene and artificial tears. To suppress inflammation, topical corticosteroids, with or without antibiotics, are frequently prescribed. However, long‐term use is limited by side effects such as increased intraocular pressure, glaucoma and/or cataract formation. Newer steroid‐sparing topical immunosuppressants have emerged as alternative treatments. Objectives To assess the benefits and harms of topical immunosuppressants for blepharitis in adults. Search methods We searched CENTRAL, MEDLINE, Embase, and three trial registries from inception to 6 April 2025. We searched the reference lists of included studies for any additional studies not identified by the electronic searches. There were no date or language restrictions on the selection of eligible studies. Eligibility criteria We included randomized controlled trials (RCTs) comparing topical immunosuppressants (corticosteroids, cyclosporine, or tacrolimus) of different doses or carrier, with placebo, no treatment, conventional treatment (lid hygiene, artificial tears) or other topical immunosuppressants in adults with blepharitis. We excluded paired‐eye studies and highly specific blepharitis subtypes. Outcomes Our outcomes were: (1) change from baseline in composite (or total) symptom score; (2) change from baseline in tear film breakup time; (3) change from baseline in corneal staining scores; (4) proportion of individuals experiencing symptomatic improvement; (5) reduction in number of or eradication of colonies of positive cultures of bacteria; (6) quality of life measures; (7) economic costs of different topical immunosuppressants; and (8) adverse effects. Risk of bias We used Cochrane's risk of bias (RoB) 2 tool for all outcomes reported in the summary of findings tables. Synthesis methods Two review authors independently selected trials, extracted data, and assessed risk of bias. We used fixed‐effect meta‐analysis to combine data and forest plots to assess heterogeneity, effect size, and direction. We used GRADE to assess the certainty of evidence for each outcome. When meta‐analysis was not possible, we used narrative synthesis. Included studies We included 12 RCTs with 2752 participants (2802 eyes) in total. Six of the trials were conducted in the USA. Topical corticosteroid was the most frequently studied immunosuppressant, followed by cyclosporine and tacrolimus. The point of assessment and duration of treatment ranged from two to 12 weeks. No study measured the proportion of individuals experiencing symptomatic improvement. Synthesis of results We report outcomes of interest for three key comparisons below at four to 12 weeks. No study assessed reduction or eradication of colonies of positive cultures of bacteria, quality of life or economic costs. Topical corticosteroids (with or without antibiotics) versus placebo The evidence is very uncertain about the effects of topical corticosteroids on composite symptom scores (corticosteroids with antibiotics: standard mean difference [SMD] 0.87, 95% confidence interval [CI] 0.31 to 1.44; 2 studies, 57 participants; corticosteroids alone: SMD ‐0.05, 95% CI ‐0.31 to 0.20; 2 studies, 232 participants; very low‐certainty evidence). No study reported tear breakup time. The evidence is very uncertain about the effects of topical corticosteroids on corneal staining scores (corticosteroids with antibiotics: MD 0.70, 95% CI ‐1.05 to 2.45; 1 study, 27 participants; corticosteroids alone: MD 0.50, 95% CI ‐1.22 to 2.22; 1 study, 27 participants); both, very low‐certainty evidence. The adverse event of irritation of the ocular surface was reported narratively and was similar between the two groups. The adverse event of ocular hypertension was reported narratively and not detected in either group in one study where it was reported. Topical corticosteroids (with or without antibiotics) versus antibiotics The evidence for topical corticosteroids was inconclusive. One study found that topical corticosteroid with antibiotic treatment may reduce symptom scores more than antibiotics alone (MD ‐11.34, 95% CI ‐13.13 to ‐9.55; 1 study, 148 participants), whereas the other found that it may have little to no effect (MD 0.40, 95% CI ‐0.11 to 0.91; 1 study, 201 participants); both, low‐certainty evidence. Topical corticosteroids plus antibiotics probably result in greater reduction in corneal staining scores compared with antibiotics alone (MD ‐1.26, 95% CI ‐1.56 to ‐0.96; 1 study, 148 participants; moderate‐certainty evidence). However, this effect was not observed for tear breakup time when antibiotics alone are likely to perform better (MD ‐1.10, 95% CI ‐1.39 to ‐0.81; 1 study, 148 participants; moderate‐certainty evidence). The adverse event of irritation of the ocular surface was reported narratively, and was similar between the two groups. The adverse event of ocular hypertension was reported narratively, and was higher in the corticosteroid (with or without antibiotics) group. Topical cyclosporine versus placebo Topical cyclosporine may have little to no effect on the composite symptom score compared with placebo, but the evidence is very uncertain (SMD 0.15, 95% CI ‐0.27 to 0.57; 2 studies, 90 participants; very low‐certainty evidence). The evidence is very uncertain about the effect of topical cyclosporine on tear breakup time compared with placebo (invasive time: MD 4.70, 95% CI ‐0.24 to 9.64; 1 study, 26 participants, although for non‐invasive time, it may provide a potential benefit: MD 1.59, 95% CI 1.48 to 1.70; 1 study, 64 participants; both very low‐certainty evidence). Topical cyclosporine...
- 4 September 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (2) , 166-172
Association of leucocyte telomere length with incident age-related macular degeneration: a prospective UK Biobank Study
Purpose There have been conflicting findings on the role of leucocyte telomere length (LTL) in the risk of age-related macular degeneration (AMD). In this study, we evaluated the associations between LTL and the risk of incident AMD and explored whether age, sex and/or genetic predisposition to AMD can modify these associations. Methods We conducted a longitudinal cohort study involving 332 123 AMD-free participants with complete baseline covariates and LTL data from the UK Biobank. We employed multivariable Cox proportional hazards models to test the association between LTL and AMD incidence, estimating the HRs and 95% CIs. Genetic risk was assessed using polygenic risk score (PRS). Results During a median follow-up of 13.63 years, 6754 participants (2.03%) developed AMD. Shorter LTL was not associated with incident AMD risk (HR=1.042, 95% CI: 0.992 to 1.094; p=0.10) after adjusting for multiple confounders. Sex showed an interactive effect with LTL (p=0.01 for interaction) on incident AMD risk, while age and PRS did not modify these associations. We identified a significant association between shorter LTL and incident AMD risk in females (HR=1.093, 95% CI: 1.025 to 1.166; p=0.007), but not in males. Moreover, shorter LTL was associated with thinner photoreceptor segments only in females at both baseline and repeated assessments (β=−0.141 µm, 95% CI: −0.267 to −0.016; β=−0.345 µm, 95% CI: −0.649 to −0.041, pConclusions Shorter LTL increased the risk of incident AMD in females, suggesting LTL as a potential biomarker for AMD development with sex-specific function.
- 4 September 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (2) , 166-172
Association of leucocyte telomere length with incident age-related macular degeneration: a prospective UK Biobank Study
Purpose There have been conflicting findings on the role of leucocyte telomere length (LTL) in the risk of age-related macular degeneration (AMD). In this study, we evaluated the associations between LTL and the risk of incident AMD and explored whether age, sex and/or genetic predisposition to AMD can modify these associations. Methods We conducted a longitudinal cohort study involving 332 123 AMD-free participants with complete baseline covariates and LTL data from the UK Biobank. We employed multivariable Cox proportional hazards models to test the association between LTL and AMD incidence, estimating the HRs and 95% CIs. Genetic risk was assessed using polygenic risk score (PRS). Results During a median follow-up of 13.63 years, 6754 participants (2.03%) developed AMD. Shorter LTL was not associated with incident AMD risk (HR=1.042, 95% CI: 0.992 to 1.094; p=0.10) after adjusting for multiple confounders. Sex showed an interactive effect with LTL (p=0.01 for interaction) on incident AMD risk, while age and PRS did not modify these associations. We identified a significant association between shorter LTL and incident AMD risk in females (HR=1.093, 95% CI: 1.025 to 1.166; p=0.007), but not in males. Moreover, shorter LTL was associated with thinner photoreceptor segments only in females at both baseline and repeated assessments (β=−0.141 µm, 95% CI: −0.267 to −0.016; β=−0.345 µm, 95% CI: −0.649 to −0.041, pConclusions Shorter LTL increased the risk of incident AMD in females, suggesting LTL as a potential biomarker for AMD development with sex-specific function.
- Open Access
- 19 August 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (1) , 101-106
Dietary omega-3 polyunsaturated fatty acids as a protective factor of myopia: the Hong Kong Children Eye Study
Purpose To evaluate the associations between omega-3 polyunsaturated fatty acids (ω-3 PUFAs) and other dietary factors with myopia. Methods A total of 1005 Chinese children, aged from 6 to 8 years, from a population-based Hong Kong Children Eye Study, were included in the analysis. Diet was assessed using a validated food-frequency questionnaire. Cycloplegic spherical equivalent (SE) refraction was assessed with an autorefractometer, and axial length (AL) by an IOL Master. Results AL was longest in the lowest quartile group of ω-3 PUFAs intake, compared with the highest (adjusted mean (95% CI), 23.29 (23.17 to 23.40) mm vs 23.08 (22.96 to 23.19) mm, p=0.01; p-trend=0.02) after adjusting for age, sex, body mass index, near-work time, outdoor time, and parental myopia history. The corresponding trends were observed in SE (−0.13 (−0.32 to 0.07) D in the lowest and 0.23 (0.03 to 0.42) D in the highest quartile groups, p=0.01; p-trend=0.01). In contrast, AL was longest in the highest quartile group of saturated fatty acids (SFA) intake, compared with the lowest (23.30 (23.17 to 23.42) mm vs 23.13 (23.01 to 23.24) mm, p=0.05; p-trend=0.04). The corresponding trends were observed in SE (−0.12 (−0.33 to 0.09) D in the highest and 0.13 (-0.04 to 0.31) D in the lowest quartile group, p=0.06; p-trend=0.04). A lower intake of ω-3 PUFAs was associated with myopia (p-trend=0.006). None of the other nutrients were associated with SE or AL or myopia. Conclusions Intake of ω-3 PUFAs is a protective factor against myopia, while higher SFA intake is a risk factor. Our findings indicated a possible effect of diet on myopia, of which ω-3 PUFAs intake may play a protective role against myopia development in children.
- 19 August 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (1) , 101-106
Open AccessDietary omega-3 polyunsaturated fatty acids as a protective factor of myopia: the Hong Kong Children Eye Study
Purpose To evaluate the associations between omega-3 polyunsaturated fatty acids (ω-3 PUFAs) and other dietary factors with myopia. Methods A total of 1005 Chinese children, aged from 6 to 8 years, from a population-based Hong Kong Children Eye Study, were included in the analysis. Diet was assessed using a validated food-frequency questionnaire. Cycloplegic spherical equivalent (SE) refraction was assessed with an autorefractometer, and axial length (AL) by an IOL Master. Results AL was longest in the lowest quartile group of ω-3 PUFAs intake, compared with the highest (adjusted mean (95% CI), 23.29 (23.17 to 23.40) mm vs 23.08 (22.96 to 23.19) mm, p=0.01; p-trend=0.02) after adjusting for age, sex, body mass index, near-work time, outdoor time, and parental myopia history. The corresponding trends were observed in SE (−0.13 (−0.32 to 0.07) D in the lowest and 0.23 (0.03 to 0.42) D in the highest quartile groups, p=0.01; p-trend=0.01). In contrast, AL was longest in the highest quartile group of saturated fatty acids (SFA) intake, compared with the lowest (23.30 (23.17 to 23.42) mm vs 23.13 (23.01 to 23.24) mm, p=0.05; p-trend=0.04). The corresponding trends were observed in SE (−0.12 (−0.33 to 0.09) D in the highest and 0.13 (-0.04 to 0.31) D in the lowest quartile group, p=0.06; p-trend=0.04). A lower intake of ω-3 PUFAs was associated with myopia (p-trend=0.006). None of the other nutrients were associated with SE or AL or myopia. Conclusions Intake of ω-3 PUFAs is a protective factor against myopia, while higher SFA intake is a risk factor. Our findings indicated a possible effect of diet on myopia, of which ω-3 PUFAs intake may play a protective role against myopia development in children.
- 18 August 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (1) , 94-100
Association of secondhand smoke exposure with child astigmatism in the Hong Kong children eye study
Backgrounds/aims Any association of secondhand smoke (SHS) with refractive astigmatism (RA) and corneal astigmatism (CA) remains unknown. This study aims to investigate the associations of SHS exposure with RA and CA in schoolchildren. Methods We conducted a population-based, cross-sectional study involving 11 545 children aged 6–8 years from the Hong Kong Children Eye Study. SHS exposure was evaluated through questionnaires, quantified by parental smoking. Child astigmatism was defined by cycloplegic autorefraction and keratometry. The associations of SHS exposure with risks and magnitudes of RA and CA were tested using logistic and linear regressions. Results 26.47% of children were exposed to SHS (mean age±SD, 7.35±0.88 years; 51.1% boys). SHS exposure was associated with the risk (OR (95% CI), 1.11 (1.00 to 1.23), p=0.04) and magnitude of RA (β (SE), −0.03D (0.01), p=0.046). Exposure to ≥10 cigarettes/day was associated with risk (OR (95% CI), 1.64 (1.23 to 2.17), pConclusion SHS exposure increases the risk and severity of child RA dose-dependently. Reduction of smoking in the presence of children or better provision of a smoke-free living environment for children is recommended.
- 18 August 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 110 (1) , 94-100
Association of secondhand smoke exposure with child astigmatism in the Hong Kong children eye study
Backgrounds/aims Any association of secondhand smoke (SHS) with refractive astigmatism (RA) and corneal astigmatism (CA) remains unknown. This study aims to investigate the associations of SHS exposure with RA and CA in schoolchildren. Methods We conducted a population-based, cross-sectional study involving 11 545 children aged 6–8 years from the Hong Kong Children Eye Study. SHS exposure was evaluated through questionnaires, quantified by parental smoking. Child astigmatism was defined by cycloplegic autorefraction and keratometry. The associations of SHS exposure with risks and magnitudes of RA and CA were tested using logistic and linear regressions. Results 26.47% of children were exposed to SHS (mean age±SD, 7.35±0.88 years; 51.1% boys). SHS exposure was associated with the risk (OR (95% CI), 1.11 (1.00 to 1.23), p=0.04) and magnitude of RA (β (SE), −0.03D (0.01), p=0.046). Exposure to ≥10 cigarettes/day was associated with risk (OR (95% CI), 1.64 (1.23 to 2.17), pConclusion SHS exposure increases the risk and severity of child RA dose-dependently. Reduction of smoking in the presence of children or better provision of a smoke-free living environment for children is recommended.